Stock Events

Stock Events

RenovoRx 

$2.36
25
-$0.01-0.42% 11:41 Today

Statistics

Day High
2.37
Day Low
2.36
52W High
2.59
52W Low
0.701
Volume
10,549
Avg. Volume
-
Mkt Cap
106.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.12
-0.1
-0.08
-0.06
Expected EPS
-0.06
Actual EPS
N/A

Financials

-994.48%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.12MRevenue
-11.17MNet Income

Analyst Ratings

8.75Average Price Target
The highest estimate is 14.50.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RNXT. It's not an investment recommendation.
Tesla
3
TSLA
Amazon
3
AMZN
Apple
2
AAPL
Microsoft
2
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bioline Rx
BLRX
Mkt Cap11.36M
BioLineRx Ltd. is involved in oncology, developing treatment options for cancer, which puts it in direct competition with RenovoRx's cancer therapy solutions.
Macrogenics
MGNX
Mkt Cap263.08M
MacroGenics, Inc. focuses on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, similar to RenovoRx's approach.
Nektar Therapeutics
NKTR
Mkt Cap2.48B
Nektar Therapeutics is involved in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms, including treatments for cancer, which competes with RenovoRx's technology.
Allogene Therapeutics
ALLO
Mkt Cap697.89M
Allogene Therapeutics, Inc. is focused on the development of allogeneic CAR T therapies for cancer, offering a different approach but competing in the broader oncology treatment market with RenovoRx.

About

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Show more...
CEO
Shaun R. Bagai
Employees
17
Country
United States
ISIN
US75989R1077

Listings

XNAS
US
RNXT
BOATS
BOATS
RNXT.BOATS

0 Comments

Share your thoughts

FAQ

What is RenovoRx stock price today?▼
The current price of RNXT is $2.36 USD — it has decreased by -0.42% in the past 24 hours. Watch RenovoRx stock price performance more closely on the chart.
What is RenovoRx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange RenovoRx stocks are traded under the ticker RNXT.
Is RenovoRx stock price growing?▼
RNXT stock has risen by +41.92% compared to the previous week, the month change is a +127.88% rise, over the last year RenovoRx has showed a +99.16% increase.
What is RenovoRx market cap?▼
Today RenovoRx has the market capitalization of 106.96M
When is the next RenovoRx earnings date?▼
RenovoRx is going to release the next earnings report on November 16, 2026.
What were RenovoRx earnings last quarter?▼
RNXT earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.07 USD resulting in a +17.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RenovoRx revenue for the last year?▼
RenovoRx revenue for the last year amounts to 1.12M USD.
What is RenovoRx net income for the last year?▼
RNXT net income for the last year is -11.17M USD.
How many employees does RenovoRx have?▼
As of September 04, 2026, the company has 17 employees.
In which sector is RenovoRx located?▼
RenovoRx operates in the Health & Wellness sector.
When did RenovoRx complete a stock split?▼
RenovoRx has not had any recent stock splits.
Where is RenovoRx headquartered?▼
RenovoRx is headquartered in MOUNTAIN VIEW, United States.